Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Primo Nutraceuticals Inc. (BUGVF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00000.0000 (0.00%)
At close: 09:34AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0000
Open0.0000
BidN/A x N/A
AskN/A x N/A
Day's Range0.0000 - 0.0000
52 Week Range0.0000 - 0.0001
Volume7,000
Avg. Volume0
Market Cap10
Beta (5Y Monthly)2.82
PE Ratio (TTM)N/A
EPS (TTM)-0.5480
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BUGVF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PRIMO NUTRACEUTICALS INC
    Analyst Report: AutoZone, Inc.AutoZone is the premier seller of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in the United States. The company derives an increasing proportion of its sales from domestic commercial customers, although its presence in its home market is still dominated by its do-it-yourself operation, which accounts for around 70% of sales in country. AutoZone also has a growing presence in Mexico and Brazil. AutoZone had 6,943 stores in the U.S. (6,168), Mexico (703), and Brazil (72) as of the end of fiscal 2022.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement